Skip to main content
Table of Contents
Print

Are There Any UK Government Programmes Supporting Cannabis For PTSD? 

Author: Dr. Clarissa Morton, PharmD

The availability of government programmes for cannabis and PTSD in the UK remains limited. While medical cannabis was legalised in 2018, access is tightly controlled and only available through specialist prescriptions. For many PTSD patients, this means cannabis treatment is technically possible but not widely supported under public health schemes. 

So far, there have been no large-scale public health initiatives offering cannabis specifically for PTSD. Most patients who receive prescriptions do so privately, as NHS access remains extremely rare. 

The Role of Government and Policy 

Understanding the UK landscape requires a closer look at how cannabis is positioned within official systems. Below are some important aspects to consider. 

Restricted NHS Access 

Only a small number of patients qualify for NHS prescriptions, and PTSD is not usually prioritised. This gap highlights the lack of official support for trauma-related cannabis use. 

Policy Development 

Although advocates continue to call for change, policy programmes in the UK have not yet embraced cannabis as a mainstream treatment for PTSD. Current focus remains on more established therapies. 

Private Pathways 

Patients often turn to private clinics for cannabis treatment. While not part of government programmes for cannabis and PTSD, these routes are currently the most common option for access. 

Overall, progress has been slow, and patients still face significant barriers. For many, the absence of strong government programmes for cannabis and PTSD underscores the need for broader reforms and clearer guidance. 

Visit providers like LeafEase for personalised consultations that explore legal and accessible cannabis treatment options for PTSD. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Post-Traumatic Stress Disorder (PTSD).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories